Reliq Health Announces Lead Subscriber Has Voluntarily Extended the Hold Period of June 2017 Private Placement to Eight Months

Reliq Health Technologies > Blog Full Left Sidebar > Press Releases > Reliq Health Announces Lead Subscriber Has Voluntarily Extended the Hold Period of June 2017 Private Placement to Eight Months

VANCOUVER, BC, December 15, 2017 / – Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, is pleased to announce that the lead subscriber from the June 2017 private placement has agreed to a voluntary extended hold period of eight months.  This extends the hold period to February 22, 2018, from the previous voluntary extended hold period of six months, which would have had a free trading date of December 22, 2017.  In the June 2017 private placement, 6,937,200 Units (the “Units”) of the Company were issued at a price of $0.11 per Unit for gross proceeds of $763,092.00.  The lead subscriber purchased 4,545,454 of these Units, which will now not be free trading until February 22, 2018.

 

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

 

For further information contact:

 

Renmark Financial Communications Inc.

Laura Welsh: lwelsh@renmarkfinancial.com

Tel: (416) 644-2020 or (514) 939-3989

www.renmarkfinancial.com

 

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

 

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

 

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

 

Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

 

SOURCE: Reliq Health Technologies Inc.